Phase II study of primary paclitaxel plus gemcitabine in patients with stage II and III breast cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Gemcitabine; Paclitaxel
- Indications Breast cancer
- Focus Therapeutic Use
- 23 Jun 2011 Biomarkers information updated
- 23 Jun 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 20 Jun 2011 Actual initiation date (Sep 2005) added as reported by ClinicalTrials.gov.